Carbamazepine Side Effects
Carbamazepine can cause serious, potentially life-threatening side effects including severe skin reactions (Stevens-Johnson syndrome, toxic epidermal necrolysis), blood disorders (aplastic anemia, agranulocytosis), liver problems, and suicidal thoughts, alongside common dose-related effects like dizziness, drowsiness, and ataxia. 1
Serious Side Effects Requiring Immediate Medical Attention
Life-Threatening Skin Reactions
- Severe cutaneous adverse reactions can be fatal and typically occur within the first 4 months of treatment 1
- Symptoms include: skin rash, hives, mouth sores, blistering or peeling skin
- Higher risk in patients of Asian descent - genetic testing (HLA-B*15:02) should be performed before initiating therapy in this population 1
- Rash occurs in approximately 10% of patients, though most cases are benign and transient 2
Hematologic (Blood) Disorders
- Aplastic anemia and agranulocytosis are rare but potentially fatal 1, 3
- Warning signs include:
- Fever, sore throat, or persistent infections
- Easy bruising or unusual bleeding
- Red or purple spots on the body
- Bleeding gums or nosebleeds
- Severe fatigue or weakness
- Leukopenia occurs in approximately 10% of patients but is usually benign and transient 2
- Historical data shows 27 cases of aplastic anemia and 10 cases of agranulocytosis reported among over 4 million treated patients 4
Hepatic and Multi-Organ Reactions
- Liver problems can occur, presenting with:
- Yellowing of skin or eyes (jaundice)
- Dark urine
- Right-sided abdominal pain
- Easy bruising, loss of appetite, nausea or vomiting 1
- Multi-organ hypersensitivity reactions may affect liver, blood cells, and other organs 1
Cardiac Effects
- Irregular heartbeat with symptoms including:
- Fast, slow, or pounding heartbeat
- Shortness of breath
- Lightheadedness or fainting 1
Psychiatric Effects
- Suicidal thoughts or actions occur in approximately 1 in 500 patients 1
- Warning signs include:
- Thoughts about suicide or dying
- New or worsening depression or anxiety
- Agitation, restlessness, panic attacks
- Insomnia, irritability, aggression
- Acting on dangerous impulses
- Mania (extreme increase in activity and talking)
Common Dose-Related Side Effects
Neurological Effects (Most Frequent)
The most common adverse events are dose-dependent and often transient, particularly during initiation or dose escalation 2, 5, 4:
- Dizziness - most frequently reported
- Drowsiness/somnolence
- Ataxia (problems with walking and coordination/unsteadiness)
- Diplopia (double vision)
- Fatigue
- Headache
These effects occurred in 30-50% of patients in clinical studies, though many patients (30-50%) remained free of side effects 4. These symptoms are usually transient and resolve with dosage adjustment 5, 4.
Gastrointestinal Effects
- Nausea
- Vomiting
- Abdominal pain 1
Other Notable Side Effects
Metabolic and Endocrine
- Hyponatremia (low sodium) 6
- Disturbances in vitamin D metabolism 5
- Disturbances in calcium metabolism 7
- Thyroid function disturbances 7
- Weight gain is uncommon (unlike many other psychiatric medications) 2
- Hyperglycemia does not occur with carbamazepine 2
Reproductive Considerations
- Reduces effectiveness of hormonal birth control 1
- May harm unborn babies during pregnancy 1
- Passes into breast milk 1
Other Adverse Effects
- Blurred vision and vertigo 6
- Tremor 6
- Hair loss 5
- Increased eye pressure 1
- Renal function disturbances 7
- Immune response disturbances 7
- Water balance disturbances 7
Critical Clinical Considerations
Do not abruptly discontinue carbamazepine - sudden cessation can cause status epilepticus (seizures that will not stop) in epilepsy patients 1. Any discontinuation must be done gradually under medical supervision.
Avoid alcohol and CNS depressants as they potentiate sedation and dizziness 1.
Avoid grapefruit and grapefruit juice as they can affect drug metabolism 1.
Proper monitoring is essential: Regular laboratory monitoring should include complete blood counts, liver function tests, and electrolytes, particularly during the first few months of therapy 7, 4. The evidence shows that 30-50% of patients experience no side effects with appropriate monitoring and dose titration 4.